UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 1, 2026
Accession Number:
0001493152-26-014239
Submission Type:
POS AM
CIK:
0001595353
Company Name:
Galmed Pharmaceuticals Ltd.
File Number:
333-289703